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Abstract This paper discusses the emerging field of nutritional psychology and provides an
update on the now completed EU-funded MooDFOOD depression prevention
randomised controlled trial that assessed the effects of two nutrition-based
interventions for the prevention of depression in overweight or obese adults with
at least mild symptoms of depression. We first outline the problem of major
depression, the most common form of psychopathology and the largest
contributor to global disability, and then give an overview of the connection
between nutrition and depression; separating the evidence according to
prevention and treatment of depression. The extant literature is reviewed, and we
examine the implications for both prevention and treatment. Questions are posed
for further research in this emerging and important area.
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Introduction
Depression
Depression is highly prevalent (Wittchen et al. 2011;
Kessler & Bromet 2013) and has become a major pub-
lic health challenge. It is ranked by the World Health
Organization (WHO) as the single largest contributor
to global disability (World Health Organization 2017)
and a major contributor to suicidal behaviour (Hegerl
et al. 2019). Depression is enormously detrimental
economically with global annual associated costs esti-
mated to stand at $1 trillion (Chisholm et al. 2016).
While there are psychological and pharmacological
treatments available, efficacy in both has been shown
to be modest (Cuijpers et al. 2016; Cipriani et al.
2018), and it has been suggested that psychotherapy
treatment effects may have been overestimated (Cui-
jpers et al. 2019).
The problem is exacerbated because more than half
of individuals develop recurrent or chronic depression,
Correspondence: Dr. Matthew Owens, Research Fellow
(Psychology), Sir Henry Wellcome Building for Mood Disorders
Research, School of Psychology College of Life and Environmental
Sciences, University of Exeter, Exeter EX4 4QG, UK.
E-mail: m.owens-solari@exeter.ac.uk
© 2020 The Authors. Nutrition Bulletin published by John Wiley & Sons Ltd on behalf of British Nutrition Foundation. 1
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the
original work is properly cited.
EMERGING RESEARCH DOI: 10.1111/nbu.12447
spending some 20% of their life with a depressive dis-
order (Cuijpers, Beekman & Reynolds 2012). While
many do receive benefit from treatment, the propor-
tion of patients in remission following psychological
or pharmacological treatment is not high, typically less
than 50% (Kolovos et al. 2017; Van Bronswijk et al.
2019). There are also a number of barriers to seeking
help including a systemic lack of economic, social, sci-
entific and human resources (Kakuma et al. 2011;
Becker & Kleinman 2013) and individual-level barri-
ers, including perceived stigma, recognising symptoms
and a preference for self-reliance (Gulliver, Griffiths &
Christensen 2010). Unfortunately, this means that
most people in need of treatment for mental health
problems do not actually receive any (Kessler et al.
2005). It has been argued that even if we could collec-
tively overcome these barriers to treatment and
achieve 100% treatment coverage, the reduction in the
burden associated with affective disorders would only
be modest (approximately 35%) (Andrews et al.
2004). This speaks to the need for more efficacious
interventions (treatment and prevention) for current
depression that is both scalable and accessible. In
addition, researchers are now increasingly focussing
on prevention intervention strategies.
With a realisation that relying on treatment only is
unlikely to be enough to help everyone in need,
depression prevention interventions have now become
a global priority (Cuijpers, Beekman & Reynolds
2012; Ebert & Cuijpers 2018). Although it was once
thought by the National Institute of Mental Health
that prevention of depression was not a realistic goal,
‘In general, the onset of a clinical depression cannot
be prevented’ (Mu~noz, Beardslee & Leykin 2012),
subsequent work has shown that prevention interven-
tions can be a viable and effective approach to depres-
sion. For example, a systematic review of
psychological interventions for the prevention of
major depressive disorder in a range of different sam-
ples (e.g. adolescents, adults, primary care samples,
pregnant women and post-stroke patients) found that
interventions were able to reduce the risk of major
depression by 21% on average compared with control
groups (van Zoonen et al. 2014). No differences were
found in this review between intervention types. That
is, cognitive behavioural therapy, interpersonal psy-
chotherapy or other (e.g. problem solving). In fact, a
number of novel approaches to preventing depression
have yielded positive results including parental pro-
grammes (Yap et al. 2016), mindfulness (Raes et al.
2014) and exercise (Harvey et al. 2018). Another
emerging area with potential is nutritional psychology.
Nutrition and depression
The aetiology of depression is complex and not yet
fully understood but is thought to involve cognitive
(Watkins 2008; Gotlib & Joormann 2010), genetic
(Mullins & Lewis 2017) and environmental (LeMoult
et al. 2020) factors, as well as physiological factors
such as hormones (Owens et al. 2014), inflammatory
markers (Lamers et al. 2019) and arousal and wake-
fulness regulation (Hegerl & Hensch 2014; Jawinski
et al. 2019). Lifestyle factors are also thought to play
a role, including most notably sleep, exercise and diet
(Lopresti, Hood & Drummond 2013). We note that
the relationship between diet, nutrition and mood is
complex and likely to involve interactions and recipro-
cal relationships between subsystems. For example, it
is suggested that stress and depression can shape gut
microbiota, which in turn may affect stress and
depression (Madison & Kiecolt-Glaser 2019). It is also
increasingly recognised that modern lifestyles may lead
to unhealthy diets, which may in turn contribute to
both an obesogenic (Garcıa, Long & Rosado 2009;
Bl€uher 2019) and depressogenic social environment
(Hidaka 2012). The obesity global pandemic (Abarca-
Gomez et al. 2017) could be linked to depression as
the two factors often co-occur (Sutaria et al. 2019).
Obesity and depression may have a bi-directional rela-
tionship where increase in one is associated with
increase in the other over time (Luppino et al. 2010;
Marmorstein, Iacono & Legrand 2014). Furthermore,
obesity and depression might share common biological
mechanisms (Milaneschi et al. 2019), including, for
example, inflammatory processes (Bullmore 2018).
One emerging approach to either the prevention or
treatment of depression aims to improve diet and
nutritional status. Under this framework, it is
acknowledged that diet and nutritional status have an
important yet complex relationship with mental health
(Sanchez-Villegas & Martınez-Gonzalez 2013; Sarris
et al. 2015; Jacka 2017; Lassale et al. 2019), and per-
haps with depression in particular (Marx, Hoare &
Jacka 2019). Theoretically, nutrients from diet or sup-
plements are able to treat or prevent depression in
two main ways: helping the brain to function well and
providing neuroprotective effects. It has been shown,
for example, that omega-3 fatty acids have pluripotent
beneficial effects in the brain by upregulating adult
neurogenesis (Beltz et al. 2007) and brain-derived neu-
rotrophic factor (BDNF) protein expression (Wu, Ying
& Gomez-Pinilla 2004; Rao et al. 2007), promoting
metabolism, release, uptake and receptor functions of
key neurotransmitter systems (e.g. serotonin and
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dopamine) (Grosso et al. 2014a) and regulating stress
via the Hypothalamic-Pituitary-Adrenal Axis (Thesing
et al. 2018). Neuroprotection from nutrients may
come in the form of anti-inflammatory processes (Wall
et al. 2010), reducing apoptosis (Harms et al. 2011)
and reducing oxidative stress (Lima et al. 2018).
Research has assessed the links between specific
nutrients and the prevention or treatment of depres-
sion. For example, dietary omega-3 is associated with
a reduced risk of depression (Grosso et al. 2016),
omega-3 supplementation versus placebo has demon-
strated a beneficial effect on depressive symptoms
(Liao et al. 2019) and vitamin D supplementation may
benefit those with clinical depression (for a review on
the connection between vitamin D and depression see
Parker, Brotchie & Graham 2017). However, it has
also been argued that single nutrient supplementation
is unlikely to be maximally effective, given that nutri-
ents are not consumed in isolation (Opie et al. 2015).
A whole-diet approach on the other hand accounts for
the complex interplay between known and unknown
nutrients in the diet. Research in this area focuses on
high-quality diets that are nutrient dense and low in
ultra-processed foods (e.g. the Mediterranean diet or
traditional diet). There is robust observational evi-
dence to suggest that such high-quality diets are at
least associated with lower risk of incident depression
(Molendijk et al. 2018; Lassale et al. 2019; Nicolaou,
Colpo & Vermeulen 2019) and in addition, there is
likely to be a complex bidirectional relationship
between the two (Elstgeest et al. 2019). However,
more work in this nascent field is needed to test the
causal status of nutrients and diet quality and the pre-
vention of depression; in particular, more randomised
controlled nutritional intervention trials (RCTs) are
required.
Nevertheless, nutrition-based approaches are attrac-
tive candidates for mental health prevention strategies
for a number of reasons including the fact that they
have the potential to reach a large number of people
and have additional wide-ranging positive health bene-
fits including promoting healthy immune function
(Wintergerst, Maggini & Hornig 2007), and reducing
negative effects of diabetes (Salas-Salvado et al. 2015),
heart disease (Grosso et al. 2017) and cancer (Aune
et al. 2011). In addition, healthy diets can encourage
healthy weight loss which may itself provide wide-
ranging health benefits, potentially including prevent-
ing depression. Several studies have shown positive
effects of behavioural weight control on both
depressed mood and weight (e.g. Brinkworth et al.
2009; Faulconbridge et al. 2018) and as a result,
nutritional interventions could also lead to health eco-
nomic benefits (Gyles et al. 2012). The recently com-
pleted MooDFOOD intervention (Roca et al. 2016;
Bot et al. 2019) is one such randomised controlled
prevention trial that investigated the role of nutrition
and nutrition-related psychological factors on depres-
sion.
The MooDFOOD prevention trial and interventions
Mental health interventions can be comprised of either
treatment or prevention strategies and we argue that
the distinction is important in depression, while recog-
nising that the boundaries between the two can be
somewhat fuzzy. Primary prevention interventions are
often classified in two main ways, as universal, applied
to the whole population for the benefit of all or tar-
geted strategies that focus on sub-populations at ele-
vated risk for a disorder. The latter can be subdivided
into selective prevention, which focusses on known
risk factors for disorder (e.g. being overweight or
obese) and indicated prevention, where subpopulations
have symptoms that may suggest emerging disorder.
Treatment interventions on the other hand are
focussed on individuals who have already received a
clinical diagnosis and may target de novo episodes of
depression or help patients with chronic depression to
prevent relapse and recurrence. In the latter case, the
line between treatment and prevention becomes
blurred, including as it does secondary prevention.
The MooDFOOD trial adopted the definition recom-
mended by the American Institute of Medicine that
prevention refers to those interventions that occur
prior to the onset of clinical disorder for individuals
who have elevated symptoms of disorder but who do
not currently meet the criteria for a clinical disorder
(O’Connell, Boat & Warner 2009).
Participants in the MooDFOOD trial (Roca et al.
2016; Cabout, Brouwer & Visser 2017; Bot et al.
2019) were overweight or obese [mean body mass
index (BMI) = 31.4], aged 18-75 years
(mean = 46.5 years) with at least mild symptoms of
depression but no current depressive episode or diag-
nosis in the past 6 months. Participants were ran-
domised to daily multi-nutrient supplementation
versus pill placebo, and to a nutritionally based psy-
chological therapy; a multi-modal food-related beha-
vioural activation intervention (F-BA); versus no
behavioural activation intervention, for a 12-month
period. In this 2 x 2 factorial trial design, participants
were therefore allocated to one of four arms: F-BA
plus supplements (n = 256), no F-BA plus supplements
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(n = 256), F-BA plus placebo (n = 256) or no F-BA
plus placebo (n = 257). Measures were collected at
baseline (T0), 3 months (T3), 6 months (T6) and at
12 months (T12; end of trial).
Multi-nutrient supplementation intervention
The daily multi-nutrient supplement included one cap-
sule of long-chain omega-3 fatty acids containing
1412 mg of eicosapentaenoic acid (EPA) and docosahex-
aenoic acid (DHA) (ratio 3:1) and a pill containing sele-
nium (30 lg), folic acid (400 lg) and vitamin D3
(20 lg) along with calcium (100 mg). The matched
placebos used included one capsule of sunflower oil
(57% linoleic acid, 30% oleic acid) and one pill with
filling materials (microcrystalline cellulose; corn starch;
polyvinylpyrrolidone; crosslinked carboxymethylcellulose
sodium; magnesium stearate and magnesium silicate).
MooDFOOD trial food-related behavioural
activation intervention
The MooDFOOD F-BA prevention intervention was
based on the standard behavioural activation therapy
(BA) for depression model (Richards et al. 2017; Veale
2008; Watkins et al. 2011; Watkins et al. 2016) which
uses self-monitoring, functional analysis and activity
scheduling to encourage individuals to increase their
engagement with activities rather than avoid them
(Ekers et al. 2014; Richards et al. 2016). There was
strong emphasis on changing habitual behaviour by
identifying triggers, planning alternative responses and
repeating behaviours routinely to develop healthy
habits, focussing on both dietary habits (e.g. reducing
snacking and encouraging a Mediterranean-style diet)
and the mood-food relationship (e.g. reducing emo-
tional eating). The F-BA intervention was delivered by
psychologists, who were trained by a nutritionist, and
consisted of up to 21 sessions, initially individual
weekly (15) and fortnightly sessions, and subsequently
monthly group (6) sessions.
There was no evidence in the MooDFOOD trial
main analyses that either intervention was efficacious
in preventing episodes of clinical depression over a 12-
month period. However, in subsequent sensitivity
analyses, F-BA was shown to reduce symptoms of
depression for those with high baseline levels and
there was a depression-prevention effect of F-BA when
intervention adherence was taken into account (Bot
et al. 2019). The results for individual nutritional sup-
plements and the F-BA and their implications in the
context of current research are discussed below.
Evidence with respect to nutritional supplements
There was neither evidence of prevention of depressive
episodes nor any beneficial effects on depressive symp-
toms for daily nutrient-supplementation in the MooD-
FOOD trial, and there was even evidence that
depressive symptom outcomes were worse for those
taking supplements versus placebo (Bot et al. 2019).
This latter result is mirrored by that of a recent treat-
ment study that administered a combination nutraceu-
tical supplement to treat patients with clinical
depression (Sarris et al. 2019). In this study, the pla-
cebo was also shown to be superior in reducing
depressive symptoms in patients, in this case over an
8-week period. The authors point to the interesting
possibility that single nutrients may be more effective
than a ‘shotgun’ approach. However, it is also impor-
tant to remain open to the possibility that nutritional
supplementation may confer iatrogenic effects on indi-
viduals with mental health problems, or for those at
risk of ill mental health. In both the MooDFOOD
prevention trial and the above treatment trial reported
by Sarris et al., the data suggest that nutritional sup-
plements compared less favourably than placebo.
However, it is important to note that neither interven-
tion was associated with a rise in depressive symptoms
per se. Therefore, a more important concern may be
that, equipped with a misguided belief that nutritional
supplements are efficacious, people with an unfolding
serious mental illness may forgo seeking treatments
that are known be effective. There is also a risk that
with an erroneous belief in a ‘magic healthy pill’,
some individuals will not see the need to follow
healthy diets and lifestyles. In this regard, we urge
caution for recommending multi-supplements for the
prevention of depression and echo a recent statement
that physicians should not recommend omega-3 sup-
plements for reducing depression risk (Deane et al.
2019).
The evidence for the efficacy of nutritional supple-
ments in depression is to some extent moderated by
treatment versus prevention, as shown by the equivo-
cal results produced from meta-analyses of RCTs on
the treatment effect of omega-3 on depression. While
some have found that initial positive results may be
explained by publication bias (Bloch & Hannestad
2012) or that effects are only small and unlikely to be
clinically meaningful (Appleton et al. 2016), others
have shown more substantial beneficial treatment
effects (Grosso 2014a; Mocking et al. 2016; Bai et al.
2018; Firth et al. 2019a; Liao et al. 2019). While
effect sizes are generally found to be small to
© 2020 The Authors. Nutrition Bulletin published by John Wiley & Sons Ltd on behalf of British Nutrition Foundation
4 M. Owens et al.
moderate (Firth et al. 2019b), these are comparable to
those found for anti-depressants (Schalkwijk et al.
2014). Interestingly, however, one meta-analysis (Hal-
lahan et al. 2016) found that omega-3 bestowed clini-
cal benefits for those diagnosed with depression but
no evidence for reduction of depressive symptoms for
populations without a depression diagnosis (although
see Grosso et al. 2014a for an alternative view). Simi-
larly, one meta-analysis (Mocking et al. 2016) found
greater treatment effects for depressed patients who
were also taking anti-depressants. In support of this
important distinction in the results between treatment
and prevention studies, the more recent meta-analysis
on the effect of omega-3 on the prevention of depres-
sion (MooDFOOD trial included) found no evidence
of a prophylactic effect (Deane et al. 2019). It should
be noted, however, that there is a paucity of research
on prevention and more is needed to draw firmer con-
clusions. In conclusion, current evidence suggests no
prevention effect of omega-3 on depression.
For treatment of depression, however, the extant
research suggests that omega-3 may be effective as an
adjunct to pharmacotherapy in terms of acceleration
of response or augmenting non-response (Schefft et al.
2017), or as a monotherapy (Hallahan et al. 2016).
EPA has been shown to more effective than DHA
(Martins, Bentsen & Puri 2012) and recommendations
for the optimal efficacious dose of EPA have been
given at approximately 1-2 grams (Guu et al. 2019),
although one meta-analysis found the most effective
dose was ≤ 1 g/day (Liao et al. 2019). In addition,
omega-3 may exert a stronger beneficial effect for
more severe cases of depression (Bloch & Hannestad
2012; Martins, Bentsen & Puri 2012), although this
effect cannot be considered a consistent finding
(Grosso et al. 2014b; Mocking et al. 2016).
Although there is less evidence available with which
to assess the efficacy of supplementation with nutri-
ents other than omega-3 in the treatment of depression
(see Firth et al. 2019b for a review), a small number
of RCTs have suggested that vitamin D supplementa-
tion may reduce depressive symptoms as a monother-
apy (Vellekkatt & Menon 2019). In the general
population, however, there is evidence for little to no
beneficial effects of vitamin D supplementation on
depressive symptoms (Elstgeest et al. 2017; De Koning
et al. 2019), while it is not currently possible to
exclude the possibility of a small beneficial effect for
those with low baseline levels of vitamin D (Elstgeest
et al. 2018) until further studies have been completed.
One trial underway is the VITAL-DEP study which is
assessing the effect of vitamin D and omega-3
supplementation on reducing the risk of clinical
depressive syndrome as well as the effect on mood
symptom scores as measured by the Patient Health
Questionnaire (Okereke et al. 2018). The results of
such trials will be informative and add to the evidence
base, enabling stronger conclusions to be made in the
future.
In addition, again with only limited evidence avail-
able, findings from meta-analysis suggests that folate
(Roberts, Carter & Young 2018) or zinc (Schefft et al.
2017) may be beneficial for patients with depressive
disorders as an adjunctive therapy to anti-depressant
medication. As an illustrative example of the findings,
one RCT administering a daily supplement of 25 mg
of zinc versus placebo in combination with a tricyclic
anti-depressant (Imipramine), depressive symptoms in
the zinc group significantly reduced for those with
treatment-resistant depression (Siwek et al. 2009).
Conversely, there is clearer evidence from RCTs show-
ing that supplementation with magnesium does not
improve symptoms in depressed patients (Phelan et al.
2018). In conclusion, the current evidence does not
support the use of supplements for the prevention of
depression. Although caution is advised and more tri-
als are required, there is some evidence to suggest that
omega-3 may give some benefit to individuals already
diagnosed with clinical depression, as an adjunctive
treatment or possibly as a monotherapy. A dearth of
RCTs for other nutrients prevents firmer conclusions
being drawn.
Evidence from behavioural approaches
The F-BA did not prevent incidence of depression in
the MooDFOOD trial, yet secondary analyses sug-
gested that the intervention may be effective for those
adhering highly to the intervention. These exploratory
analyses showed that for those with high adherence,
the F-BA lead to a 22% reduction in the incidence of
clinical depression over the course of the trial, an
effect which is comparable with previous psychologi-
cal prevention interventions (van Zoonen et al. 2014).
Secondary analyses also showed that the F-BA reduced
symptoms of depression at 12-month follow-up for
those with higher initial severity of depressive symp-
toms (Bot et al. 2019).
Although it is certainly possible that the underlying
cause of the reduction in symptoms seen for some par-
ticipants in the F-BA trial arm could be the (relatively
small) reduction in unhealthy food consumption and
increase in healthy food consumption (Grasso et al.
2019), our more recent analyses suggest that it is
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unlikely that targeting food consumption alone will
have a strong effect of reducing symptoms of depres-
sion. In mediation analyses on the MooDFOOD trial
data, we found no evidence to suggest that increasing
diet quality or reducing snacking per se explained the
apparent small beneficial effect of F-BA on depressive
symptoms (Owens et al., manuscript submitted for
publication). In this analysis, we did, however, find
that reductions in negative responses to food cues (i.e.
unrestrained eating and emotional eating) partially
explained the link. This is consistent with previous
analyses linking depression to these unhealthy eating
styles in the MooDFOOD cohort (Paans et al. 2018).
This evidence leads us to speculate that learning alter-
native habitual, healthier responses to such cues may
be a modifiable target for future interventions. A simi-
lar view can be found in research with patients with
obesity, where it has been proposed that the interac-
tion between psychological habits, mood and emo-
tional dysregulation is thought to be key in reducing
clinical obesity (see Raman, Smith & Hay 2013).
The F-BA in MooDFOOD has also been shown to
be feasible to carry out and was acceptable to the
majority of participants in the MooDFOOD trial
(Owens et al., manuscript submitted for publication),
which leaves open the possibility of refining and
further developing this novel approach to depression
prevention, combining both nutritional and psycholog-
ical/behavioural components. In this study, we found
a clear preference for individual versus group, which
has also been found for mental health treatment in
primary care (Lang 2005). When designing interven-
tions it is important to consider patient preference, a
factor that can predict good outcomes for individuals,
as shown by a recent study with depressed patients
showing a preference for one treatment over another
(person-centred counselling vs. low intensity cognitive
behavioural therapy) predicted the best treatment out-
comes (Cooper et al. 2018). Furthermore, evidence
from meta-analysis has demonstrated smaller thera-
peutic effects for group versus individual psychother-
apy for depressed patients (Cuijpers et al. 2014).
Whole-diet approaches
When comparing the evidence of whole-diet interven-
tions on depressive and anxiety symptoms, a recent
meta-analysis of 16 RCTs (the vast majority assessing
non-clinical depression) suggests that the whole-diet
approach may provide a small yet significant positive
benefit in reducing symptoms of depression (Firth
et al. 2019a). Effect sizes (Hedge’s g) for the
interventions were similar for depressive symptoms
when comparing those that aimed to improve nutri-
tion [K (number of studies) = 9, 0.365] and those aim-
ing to reduce fat intake (K = 4, 0.477), while the
effect size was smaller for those interventions focuss-
ing on weight loss (K = 4, 0.212). Fifteen studies in
this review of the literature were comprised of non-
clinical populations, with a single study, the SMILES
trial, using a clinical depression sample (Jacka et al.
2017). This study observed a very large difference in
the reduction of depression symptoms for a dietary
support group versus a social support group (Cohen’s
d effect size of –1.16). The only other whole-diet RCT
for clinical depression that we are aware of, and not
included in the recent review by Firth et al. (2019a) is
the HELFIMED trial (Parletta et al. 2019). This trial
recruited patients with general practitioner (GP)-re-
ported or self-reported depression and randomised
them to either a ‘MedDiet’ group receiving nutrition
education from dietitians and nutritionists, Mediter-
ranean-style food hampers, cooking workshops and
fish oil supplements for 6 months, or to fortnightly
social groups for 3 months. The results showed statis-
tically significant reductions in symptoms of depres-
sion for the MedDiet group, where 60% fewer
participants experienced ‘extremely severe’ depression.
A further clinical trial to look out for with results
forthcoming is the PREDI-DEP trial. This trial is
assessing the effect a dietitian-led Mediterranean-style
diet supplemented with olive oil on the prevention of
the recurrence of disorder for participants with a his-
tory of clinical depression (Sanchez-Villegas et al.
2019).
Role of weight loss
The focus of the MooDFOOD trial was on the pre-
vention of depression and the change in depressive
symptoms rather than weight loss per se and consis-
tent with this, trial participants lost less than 1 kilo-
gram of weight in the trial arms (0.3–0.8 kg), after
1 year of being in the study, with no significant differ-
ence between trial arms (Bot et al. 2019). Interven-
tions that specifically target weight loss with
psychotherapy, however, have been shown to reduce
emotional eating and cognitive restraint, but current
meta-analytic evidence suggests that cognitive beha-
vioural therapy specifically for weight loss (CBTWL)
is not superior to other interventions for depression
(Jacob et al. 2018). In this recent meta-analysis, the
majority of studies were not designed specifically to
reduce depression but interestingly one included study
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with obese women (Pagoto et al. 2013) which used
BA (as did MooDFOOD), reported reductions in
depressive symptoms and associated weight loss. More
recently, the RAINBOW RCT for patients with both
obesity and high levels of depressive symptoms
showed that an integrated intervention including a
weight loss programme and psychological therapy
including BA, reduced both BMI and depressive symp-
toms (Ma et al. 2019). In this study, baseline depres-
sive symptoms on the Patient Health Questionnaire
were higher than in the MooDFOOD trial (13.8 vs.
7.4 in MooDFOOD), adding credence to the sugges-
tion that behavioural approaches may be more effec-
tive for individuals with a higher level of baseline
symptomatology.
Conclusions and future directions
The nutrition-based approach to treat or prevent
depression reviewed here is a promising emerging field
that warrants further investigation. Treatment and
prevention of common mental health problems, such
as depression, is a pressing global priority and more
resources should be devoted to understanding what
works and for whom. We do not underestimate the
need for treatment of depression and indeed believe
that more resources should be devoted to develop new
treatments than is currently the case. We do empha-
sise, however, the need for greater efforts on preven-
tion. As has been pointed elsewhere, our society tends
to focus on the ‘rule of rescue’ rather than prevention.
However, this may well be ‘collective health care myo-
pia’ (O’Connell, Boat & Warner 2009). Prevention
efforts are not visible in the same way that treatment
effects are but can deliver cost-effective outcomes
(Ebert & Cuijpers 2018). It is also important to con-
sider that even small reductions in depressive symp-
toms on a population scale are likely to produce an
enormous public health benefit (Mu~noz et al. 2016).
Although there are still very few RCTs assessing
integrative nutritional and psychological approaches
to depression prevention, the current literature
includes evidence, albeit limited, that nutritional sup-
plements are not effective for the prevention of depres-
sion. It therefore remains an open question as to
whether future nutrition-based interventions will have
the ability to prevent depression. There is some evi-
dence, on the other hand, for small beneficial effects
of omega-3 supplements in the treatment of depression
as an adjunctive therapy. Whole-diet approaches may
yield beneficial effects on depressive symptoms in clini-
cal depression (see the SMILES trial; Jacka et al.
2017), although the majority of studies have used
non-clinical populations (Firth et al. 2019b). This lat-
ter fact leaves open the possibility that there is poten-
tial for depression prevention effects through whole-
diet approaches, but more research is needed in this
area to ascertain this.
We have also noted here that we should proceed
with caution to ensure that we do not cause harm,
either directly through any iatrogenic effects (e.g. neg-
ative effects of supplements) or by inadvertently sign-
posting those in need, whether they are patients with
clinical depression or individuals with elevated symp-
toms or with known risk factors for disorder, to inef-
fective interventions, when they might otherwise seek
help from interventions known to be efficacious.
Moreover, there are a number of important ques-
tions that remain unanswered in the emerging area of
nutritional psychology including but not limited to,
what components make an intervention work? For
whom will they be most effective? What are the
underlying mechanisms at play? Are they more effec-
tive for prevention or treatment? Under which condi-
tions will an intervention work and when will they
not? For example, in the MooDFOOD depression
prevention trial, the behavioural intervention was only
able to prevent depression in those with good adher-
ence to the protocol and was only able to reduce
symptoms of depression for those with higher initial
symptom levels. Several nutrition-related candidate
mechanisms of action are plausible in depression pre-
vention and treatment interventions, and future
research needs to tease these out. For example, is
change in nutrient status the key intervention ingredi-
ent (or perhaps only in those with an initially low sta-
tus), or perhaps, as we have ventured, swapping a
range of unhealthy behaviours for more healthy ones,
and making these habitual?
Equally, we need to know whether these types of
intervention are more effective as an indicated preven-
tion when a disorder is unfolding, or as a treatment
for severely depressed patients, or alternatively, more
as recurrence prevention. Who should deliver the
intervention to maximise its effectiveness? For
instance, in the review of diet quality interventions on
depression (Firth et al. 2019a), involvement of a nutri-
tional professional (e.g. dietitians or nutritionists) in
delivering dietary interventions was associated with a
significant reduction in depressive symptoms, whereas
interventions without such involvement fared no better
than control. We also do not know what the optimal
nutrient levels should be for mental health and wellbe-
ing and so a nutrition-based intervention may be
© 2020 The Authors. Nutrition Bulletin published by John Wiley & Sons Ltd on behalf of British Nutrition Foundation
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personalised based on, for example, individual differ-
ences in initial omega-3 levels or perhaps levels of
inflammatory markers or their combination (Guu
et al. 2019). These and other questions should be the
focus of future research and given the often-blurred
boundaries between prevention and treatment, a
blended model of intervention in depression may be a
useful way to plan future work. We illustrate one such
model in Figure 1, adapted from O’Connell, Boat and
Warner (2009) and applied to the case of depression.
Prevention of depression may begin with health pro-
motion that includes psychoeducation on lifestyle fac-
tors known to be important in the etiopathogenesis of
the disorder such as diet, sleep and exercise (Lopresti
2019), or more broadly building resilience to stress.
Prevention of de novo depressions could be
approached through universal programmes, such as
dietary advice based on national dietary guidelines
and promoting positive healthy habits, or used in a
selective way for individuals with known risk factors
for depression. Alternatively prevention may be indi-
cated, where high levels of symptoms are present in
individuals but without disorder (e.g. Van Voorhees
et al. 2009). Personalised, or precision approaches to
intervention, including both prevention and treatment,
could be facilitated through a person-centred approach
of formulation, which summarises and integrates a
broad range of biopsychosocial putative causal factors.
For example, identifying diet quality, nutrient status,
psychological and behavioural patterns as well as
somatic and psychological symptoms may guide pro-
fessionals towards a more tailored intervention for a
given individual. Whether these approaches will turn
out to be valid is an empirical question and we need
to collect sufficient evidence before proceeding. As
discussed, depression can run a chronic course and
relapse is a major problem (Cuijpers, Beekman &
Reynolds 2012) and so future research should also test
the best approaches to prevention of relapse or recur-
rence. Finally, recognising that the ultimate goal for
some is not simply the absence of disorder, interven-
tion should ideally also consider ways in which to also
enhance more positive outcomes of wellbeing and
flourishing (Huppert & So 2013).
Finally, we recognise that depression is a complex
and heterogenous problem likely to involve a number
of interacting lifestyle factors, not only diet and nutri-
tion. The nature of these interactions and their relative
contribution in depression should be the focus of basic
science, applied research as well as clinical practice.
In conclusion, the psychological-nutritional
approach has shown promise for mental health and
depression treatment in particular but more work is
needed to understand the optimal strategies for those
in need, whether that means health promotion, graded
prevention or treatment, recurrence prevention or
facilitating greater wellbeing/flourishing, helping peo-
ple to live the life that they want to. More basic
science as well as rigorous, high-quality RCTs con-
ducted in well-described groups (e.g. those at higher
risk, clinical patients, those with a history of depres-
sion) are required to help us understand the underly-
ing mechanisms and moderating factors involved, and
to test novel interventions in the emerging field of
nutritional psychology.
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